Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Preventive Medicine|April 10, 2023
Paraoxonase 1 Activity is Associated with Interleukin-6 Levels in Type 2 Diabetes: Effects of Age and GenderArmin Nikzad, Ahad Alizadeh, Saeid Abediankenari, et al.
Neuroscience|April 10, 2025
microRNAs as molecular tools for brain health: Neuroprotective potential in neurodegenerative disordersMozhgan Abasi, Anvarsadat Kianmehr, Athena Variji, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 15, 2021
Role of microRNAs in the anticancer effects of the flavonoid luteolin: a systematic reviewMohammad Amir Mishan, Mohammad Amin Khazeei Tabari, Abdolkarim Mahrooz, et al.
IUBMB Life|August 5, 2011
Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidationDavid Hine, Bharti Mackness, Mike Mackness
Current Opinion in Lipidology|July 10, 2004
Paraoxonase 1 activity, concentration and genotype in cardiovascular diseaseMike Mackness, Paul Durrington, Bharti Mackness
Free Radical Biology & Medicine|July 1, 2008
Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stressYifen Liu, Bharti Mackness, Mike Mackness
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 13, 2021
Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionalityAbdolkarim Mahrooz, Yasaman Shokri, Atena Variji, et al.
Diabetes|October 27, 2006
Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetesMaria Mastorikou, Mike Mackness, Bharti Mackness
Journal of Diabetes and Metabolic Disorders|October 6, 2018
Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetesDurdi Qujeq, Abdolkarim Mahrooz, Ahad Alizadeh, et al.
Journal of Clinical and Diagnostic Research : JCDR|July 21, 2016
Association of APOA5 Gene Promoter Region -1131T>C Polymorphism (rs662799) to Plasma Triglyceride Level in Patients with Type 2 Diabetic NephropathyAbdolkarim Mahrooz, Mehryar Zargari, Vahid Ansari, et al.
Pageof 8